Safety and immunogenicity in piglets of the vaccine candidate E2-CD154, a subunit vaccine against classical swine fever. Results from phase III clinical trial
Revista de salud animal, 2023, Vol.45 [Peer Reviewed Journal]This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. ;ISSN: 2224-4700 ;EISSN: 2224-4700
Full text available